Empirically defining trajectories of late-life cognitive and functional decline
Manuscript Number:
15-0563R1
Author(s):
MIchael Case, Elisabeth Degenhardt, David B. Henley, Helen Hochstetler, Jeannie-Marie Leoutsakos, Constantine G. Lyketsos, Paula T. Trzepacz, Shufang Wang, Peng Yu
Honorarium or travel support from Pfizer, Forest, GlaxoSmithKline, Health Monitor
Grants
Agency:
Forest, GlaxoSmithKline, Eisai, Pfizer, AstraZeneca, Lilly, Ortho-McNeil, Bristol-Myers, Novartis, National Football League, Elan, Functional Neuromodulation